NCT07518329
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07518329
Title Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arovella Therapeutics Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Royal Adelaide Hospital Adelaide South Australia 5000 Australia Details
The Alfred Hospital Melbourne Victoria 3004 Australia Details
Epworth HealthCare Richmond Victoria 3121 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field